BELTON, Texas, Nov. 12, 2025 /PRNewswire/ — Armor Health (ArmorHealthcare.com), a leading national provider of integrated correctional healthcare, was awarded a…
– Using Ascletis’ proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35,…
BRISBANE, Australia, Nov. 12, 2025 /PRNewswire/ — Laronix, (“Laronix” or the “Company”), a commercial-stage medical technology (MedTech) company and an industry-leading…